Sherry Soefje
Psychiatry · Oceanside, CANPI 1639260201
Payments from drug & device makers
Across 1,665 payments — averaging $7157.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2.9M
- Teva Pharmaceuticals USA, Inc.$1.8M
- Sage Therapeutics, LLC$1.1M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$961K
- Bioxcel Therapeutics, Inc.$711K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$651K
- plus $3.8M from 24 others
Across 38 payments — averaging $151.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
- AbbVie$3K
- Teva Pharmaceuticals USA, Inc.$76
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$11,917,500 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Oceanside
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
- Gustavo AlvaOrange$9.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.